Unaudited Condensed Consolidated Statement of Cash Flows Statement (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income	$ 58,722	$ 48,315
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,447	29,541
Amortization of intangible assets	5,808	6,149
Amortization of cemetery property	8,975	9,569
Amortization of loan costs	1,235	1,194
Provision for doubtful accounts	1,720	2,842
Provision for deferred income taxes	26,134	18,479
Losses (gains) on divestitures and impairment charges, net	969	490
Share-based compensation	2,830	2,574
Excess tax benefits from share based awards	(772)	0
Change in assets and liabilities, net of effects from acquisitions and divestitures:
Decrease in receivables	5,962	4,471
Increase (decrease) in other assets	(5,882)	(5,352)
Increase (decrease) in payables and other liabilities	12,215	(7,888)
Effect of preneed funeral production and maturities:
Decrease in preneed funeral receivables, net and trust investments	13,738	16,066
Decrease in deferred preneed funeral revenue	(4,000)	(7,735)
Decrease in deferred preneed funeral receipts held in trust	(14,176)	(10,069)
Effect of cemetery production and deliveries:
Increase in preneed cemetery receivables, net and trust investments	(6,359)	(26,238)
Increase in deferred preneed cemetery revenue	15,912	15,948
(Decrease) increase in deferred preneed cemetery receipts held in trust	(3,419)	642
Other	1,065	(3,214)
Net cash provided by operating activities	151,124	95,784
Cash flows from investing activities:
Capital expenditures	(22,569)	(23,378)
Acquisitions	0	(804)
Proceeds from divestitures and sales of property and equipment, net	1,816	264
Net withdrawals of restricted funds and other	339	1,176
Net cash used in investing activities	(20,414)	(22,742)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	0	907
Payments of debt	(4,948)	(497)
Principal payments on capital leases	(6,468)	(6,084)
Proceeds from exercise of stock options	3,094	2,323
Excess tax benefits from share based awards	772	0
Purchase of Company common stock	(1,708)	(75,106)
Payments of dividends	(12,698)	(11,104)
Payments to Acquire Additional Interest in Subsidiaries	(8,333)
Bank overdrafts and other	(4,004)	433
Net cash used in financing activities	(34,293)	(89,128)
Effect of foreign currency on cash and cash equivalents	(579)	1,348
Net decrease in cash and cash equivalents	95,838	(14,738)
Cash and cash equivalents at beginning of period	92,708	128,569
Cash and cash equivalents at end of period	$ 188,546	$ 113,831